We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

EU Attack On Drug IP Practices Presents Challenges

Law360 (December 1, 2008, 12:00 AM EST) -- The European Commission's report last week accusing major drug companies of working to delay or block the sale of generic versions of their medicines presents a number of challenges both for drugmakers and the commission, competition and intellectual property lawyers say.

The report, which consists of the preliminary findings of an investigation begun in January, criticized several widespread practices in the pharmaceutical industry, such as filing multiple patent applications for the same drug and settlement deals that require generics makers to stay out of the market...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.